SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings is trending due to a combination of factors, including recent earnings and a low float, leading to speculation about a potential short squeeze. The community is actively discussing price levels, profit-taking strategies, and the stock's potential for significant upward movement. Some traders are wary of the stock's history and caution against chasing gains.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recently announced $5 million production order and a $150 million registered direct offering, signaling strong institutional investor confidence. The community is actively discussing the implications of these developments for POET's growth in the AI infrastructure market and its potential to scale production. Discussions include comparing POET to other companies and analyzing the significance of partnerships with major industry players in photonics.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors anticipate upcoming earnings, potential rate cuts, and possible S&P 500 inclusion. The community is bullish, fueled by optimism around growth prospects, crypto offerings, and increasing membership. Many see a breakout above the $30 resistance level and are discussing potential price movements post-earnings.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is trending as investors discuss the potential acquisition of Larvotto Resources and the implications of a rejected initial offer, alongside the company's existing DLA contract. Community members are debating the deal's valuation and potential government involvement, while emphasizing UAMY's position as a key domestic antimony producer amid global supply chain concerns and China's export policies. There is also growing anticipation for upcoming earnings announcements and speculation about new deals with Australia and NATO.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending after successful flight testing of its Black Widow drone using Palantir's visual navigation software in GPS-denied conditions, marking a potential breakthrough for military applications. The community is actively discussing the implications of this advancement and possible contract opportunities. Some investors express excitement and long-term bullish sentiment, while others are wary of short-term volatility and are actively trading the stock.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Avidity Biosciences Inc

Avidity Biosciences ($RNA) is trending following news of a potential acquisition by Novartis, with the deal speculated to strengthen Novartis's neuroscience pipeline. The community is buzzing about the potential buyout price, the value of the spin-off company, and the implications for the broader RNA therapeutics sector. Some traders point to options activity as a signal and congratulate long-term holders.

YPF SA engages in the exploration, production, and distribution of oil and gas. It operates through the following segments: Upstream, Gas and Power, Downstream, Central Administration and Other. The Upstream segment sells petroleum and natural gas. The Gas and Power segment markets natural gas to third parties and downstream segment; and manages commercial and technical LNG Regasification Terminals in Bahia Blanca and Escobar. The Downstream segment produces petroleum refining and petrochemicals. The Central Administration and Other segment covers corporate administrative expenses and assets, construction activities, and the environmental remediation. The company was founded on June 2, 1977 and is headquartered in Buenos Aires, Argentina.

YPF - ADR

YPF S.A.

YPF is trending due to a rally in Argentina-focused equities, sparked by Javier Milei's election victory; the community is discussing the potential impacts of his policies, including privatization and dollarization, on YPF and the broader Argentine market, while also considering technical factors and unusual options activity.

Banco BBVA Argentina SA engages in the provision of banking and financial services. It operates through the following business lines: retail banking; small and medium-sized companies; and corporate and investment banking (CIB). The retail banking business includes checking and savings accounts, time deposits, credit cards, personal and auto loans, mortgages, insurance, and investment products. The small and medium-sized companies business focuses on local private-sector companies. The CIB business covers global transaction services and global markets solutions such as risk management and securities brokerage, long term financing products as well as project finance and syndicated loans, and corporate finance services. The company was founded on October 14, 1886 and is headquartered in Buenos Aires, Argentina.

BBVA Argentina - ADR

Banco Bbva Argentina SA

BBAR is trending as investors monitor Argentinian equities following recent political developments, with some anticipating a potential rally due to a shift in leadership. Community members are actively discussing the stock's potential for significant gains, while acknowledging the inherent volatility and risks associated with the Argentinian market. The stock's low P/E ratio and the potential for increased foreign investment are also key discussion points.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

SNDX is trending as investors discuss its potential acquisition by INCY and compare it to competitor KURA, particularly focusing on the safety profiles of their respective leukemia treatments. Community members are weighing the impact of a recent FDA approval for Syndax's Revuforj against concerns over a "black box" warning, while also evaluating future revenue potential and possible buyout scenarios.

Global X Funds - Global X MSCI Argentina ETF

The Argentina ETF, ARGT, is trending due to optimism surrounding Argentina's economic direction, particularly following recent political developments and government actions. Community discussions revolve around the potential impact of these changes and the fund's future performance, with some noting the country's ongoing economic challenges. Investors are closely watching how new policies will affect the fund's holdings and the broader Argentinian market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Will Biogen Beat on Q3 Earnings? Leqembi, Skyclarys Could Hold the Key

Biogen is expected to top earnings forecasts again as new products offset declining multiple sclerosis drug sales.

Why Supernus (SUPN) is Poised to Beat Earnings Estimates Again

Supernus (SUPN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks.com featured highlights include United Natural Foods, Teladoc Health, Supernus and BRP

Zacks highlights United Natural Foods, Teladoc Health, Supernus, and BRP as strong relative price strength stocks positioned to outperform in volatile markets.

Can 4 Relative Price Strength Stocks Defy Market Swings?

UNFI, TDOC, SUPN and BRP shine with strong relative price strength, earnings momentum, and analyst upgrades amid volatile markets.

Supernus Pharmaceuticals (SUPN) Is Up 2.81% in One Week: What You Should Know 

Does Supernus Pharmaceuticals (SUPN) have what it takes to be a top stock pick for momentum investors? Let's find out.

Can Biogen Stock Rebound as New Drugs Aim to Offset MS Sales Declines?

Biogen's new drugs Leqembi, Skyclarys and Zurzuvae are driving fresh momentum, but MS and Spinraza declines cloud its growth path.

Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run?

Supernus (SUPN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Are You Looking for a Top Momentum Pick? Why Supernus Pharmaceuticals (SUPN) is a Great Choice

Supernus Pharmaceuticals, Inc. (SUPN) Hit a 52 Week High, Can the Run Continue?

Biogen Gets EU Nod for First Postpartum Depression Drug

BIIB secures EU approval for Zurzuvae, the first oral treatment for postpartum depression, boosting its long-term growth prospects.

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

Supernus Pharmaceuticals Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$52.83
Prev Close	$52.02
Open	$52.30
Dividend Yield	0.00%
50-Day Moving Average	$46.82
Beta	0.56
Avg. Volume	689,652.52
PE Ratio	46.17

52-Week High	$53.28
52-Week Low	$29.16
Market Capitalization	$2.96B
EPS (Annual)	$1.32
Price to Book	2.79
Revenue Per Employee	$981,924.33
Enterprise Value/EBITDA	N/A

SUPN
Supernus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SUPN News

SUPNSupernus Pharmaceuticals Inc